Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors

References

• de Duve C. Lysosomes revisited. Eur J Biochem 1983; 137: 391–397
   PubMedGoogle Scholar
• Brömme D, Kaleta J. Thiol-depedent cathepsins: Pathophysiological implications and recent advances in inhibitor design. J Curr Pharm Des 2002; 8: 1639–1658
   PubMed Web of Science ®Google Scholar
• Fehrenbacher N, Jaattela M. Lysosomes as targets for cancer therapy. Can Res 2005; 65: 2993–2995
   PubMed Web of Science ®Google Scholar
• Guicciardi ME, Miyoshi H, Bronk SF, Gores GJ. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: Implications for therapeutic applications. Am J Pathol 2001; 159: 2045–2054
   PubMed Web of Science ®Google Scholar
• Kakegawa H, Nikawa T, Tagami K, Kamioka H, Sumitani K, Kawata T, Drobnic-Kosorok M, Lenarcic B, Turk V, Katunuma N. Participation of cathepsin L on bone resorption. FEBS Lett 1993; 321: 247–250
   PubMed Web of Science ®Google Scholar
• Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 1996; 271: 12511–12516
   PubMed Web of Science ®Google Scholar
• Brix K, Lemansky P, Herzog V. Evidence for extracellularly acting cathepsins mediating thyroid hormone liberation in thyroid epithelial cells. Endocrinology 1996; 137: 1963–1974
   PubMedGoogle Scholar
• Chapman HA. Endosomal proteolysis and MHC class II function. Curr Opin Immunol 1998; 10: 93–102
   PubMed Web of Science ®Google Scholar
• Esser RE, Angelo RA, Murphey MD, Watts LM, Thornburg LP, Palmer JT, Talhouk JW, Smith RE. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum 1994; 37: 236–247
   PubMed Web of Science ®Google Scholar
• Katunuma N, Kominami E. Abnormal expression of lysosomal cysteine proteinases in muscle wasting diseases. Rev Physiol Biochem Pharmacol 1987; 108: 1–20
   PubMedGoogle Scholar
• Navab R, Chevet E, Authier F, Di Guglielmo GM, Bergeron JJM, Brodt P. Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions. J Biol Chem 2001; 276: 1364–1369
   Google Scholar
• Sheahan K, Shuja S, Murnane MJ. Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 1989; 49: 3809–3814
   PubMed Web of Science ®Google Scholar
• Elliot E, Sloane BF. The cysteine protease cathepsin B in cancer. Perspect Drug Disc Des 1996; 6: 12–32
   Google Scholar
• Hoshimoto Y, Kondo C, Kojima T, Magata H, Moriyama A, Hayakawa T, Katunuma M. Significance of 32-kDa cathepsin L secreted from cancer cells. Cancer Biother. Radiopharm 2006; 21: 217–224
   Google Scholar
• Ravanko K, Järvinen K, Helin J, Kalkkinen N, Hölttä E. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts. Cancer Res 2004; 64: 8831–8838
   PubMedGoogle Scholar
• Rousselet N, Mills L, Jean D, Tellez C, Bar-Eli M, Frade R. Inhibition of umorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res 2004; 64: 146–151
   PubMed Web of Science ®Google Scholar
• Löser R, Schilling K, Dimmig E, Gütschow M. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles. J Med Chem 2005; 48: 7688–7707
   PubMed Web of Science ®Google Scholar
• Otto HH, Schirmeister T. Cysteine proteases and their inhibitors. Chem Rev 1997; 97: 133–171
   PubMed Web of Science ®Google Scholar
• Yamashita DS, Dodds RA. Cathepsin K and the design of inhibitors of cathepsin K. Curr Pharm Des 2000; 6: 1–24
   PubMed Web of Science ®Google Scholar
• Donmienne L, Giovanni A, David PF. Protease inhibitors: current status and future prospects. J Med Chem 2000; 43: 305–341
   PubMedGoogle Scholar
• Rosenthal PJ, Wollish WS, Palmer JT, Rasnick D. J Clin Invest 1991; 88: 1467–1472
   PubMed Web of Science ®Google Scholar
• Palmer JT, Rasnick D, Klaus JL, Bromme D. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem 1995; 38: 3193–3196
   PubMed Web of Science ®Google Scholar
• Hanada K, Tamai M, Yamagishi M, Ohmura S, Sawada J, Tanaka I. Isolation and characterization of E-64, a new thiol protease inhibitor. Agric Biol Chem 1978; 42: 523–528
   Web of Science ®Google Scholar
• Tavares FX, Boncek V, Deaton DN, Hassell AM, Long ST, Miller AB, Payne AA, Miller LR, Shewchuk LM, Wells-Knecht K, Willard DH, Jr., Wright LL, Zhou HQ. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin K. J Med Chem 2004; 47: 588–599
   PubMed Web of Science ®Google Scholar
• Yasuma T, Oi S, Choh N, Nomura T, Furuyama N, Nishimura A, Fujisawa Y, Sohda T. Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption. J Med Chem 1998; 41: 4301–4308
   PubMed Web of Science ®Google Scholar
• Liang TC, Abeles RH. Inhibition of papain by nitriles: Mechanistic studies using NMR and kinetic measurements. Arch Biochem Biophys 1987; 252: 626–634
   PubMedGoogle Scholar
• Ando R, Sakaki T, Morinaka Y, Takahashi C, Tamao Y, Yoshii N, Katayama S, Saito K, Tokuyama H, Isaka M, Nakamura E. Cyclopropenone containing cysteine protease inhibitors: Synthesis and enzyme inhibitory activities. Bioorg Med Chem 1999; 7: 571–579
   PubMedGoogle Scholar
• Marquis RW, Ru Y, LoCastro SM, Zeng J, Yamashita DS, Oh H,-J, Erhard KF, Davis LD, Tomaszek TA, Tew D, Salyers K, Proksch J, Ward K, Smith B, Levy M, Cummings MD, Haltiwanger RC, Trescher G, Wang B, Hemling ME, Quinn CJ, Cheng H,-Y, Lin F, Smith WW, Janson CA, Zhao B, McQueney MS, D'Alessio K, Lee C,-P, Marzulli A, Dodds RA, Blake S, Hwang S,-M, James IE, Gress CJ, Bradley BR, Lark MW, Gowen M, Veber DF. Azepanone-based inhibitors of human and rat cathepsin K. J Med Chem 2001; 44: 1380–1395
   PubMed Web of Science ®Google Scholar
• Harbeson SL, Abelleira SM, Akiyama A, Barrett C, III R, arroll RM, Straub JA, Tkacz JN, Wu C, Musso GF. Stereospecific synthesis of peptidyl α-keto amides as inhibitors of calpain. J Med Chem 1994; 37: 2918–2929
   PubMed Web of Science ®Google Scholar
• Altmann E, Renaud J, Green J, Farley D, Cutting B, Jahnke W. Arylaminoethyl amides as novel noncovalent cathepsin K inhibitors. J Med Chem 2002; 45: 2352–2354
   PubMed Web of Science ®Google Scholar
• Moon JB, Coleman RS, Hanzlik R-P. Reversible covalent inhibition of papain by a peptide nitrile. 13C NMR evidence for a thioimidate ester adduct. J Am Chem Soc 1986; 108: 1350–1351
   Web of Science ®Google Scholar
• Brisson J-R, Carey PR, Storer AC. Benzoylamidoacetonitrile is bound as a thioimidate in the active site of papain. J Biol Chem 1986; 261: 9087–9089
   PubMedGoogle Scholar
• Ward YD, Thomson DS, Frye LL, Cywin CL, Morwick T, Emmanuel MJ, Zindell R, McNeil D, Bekkali Y, Giradot M, Hrapchak M, DeTuri M, Crane K, White D, Pav S, Wang Y, Hao M,-H, Grygon CA, Labadia ME, Freeman DM, Davidson W, Hopkins JL, Brown ML, Spero DM. Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors. J Med Chem. 2002; 45: 5471–5482
   PubMed Web of Science ®Google Scholar
• Peters JU. 11 Years of cyanopyrrolidines as DPP - IV inhibitors. Curr Top Med Chem 2007; 7: 579–595
   PubMed Web of Science ®Google Scholar
• Fukushima H, Hiratate A, Takahashi M, Saito M, Munetomo E, Kitano K, Saito H, Takaoka Y, Yamamoto K. Synthesis and structure-activity relationships of potent 3- or 4-substituted-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors. Bioorg Med Chem 2004; 12: 6053–6061
   PubMedGoogle Scholar
• Calkins CC, Sloane BF. Mammalian cysteine protease inhibitors: Biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995; 376: 71–80
   PubMed Web of Science ®Google Scholar
• Falgueyret JP, Oballa RM, Okamoto O, Wesolowski G, Aubin Y, Rydzewski RM, Prasit P, Riendeau D, Rodan SB, Percival MD. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L. J Med Chem 2001; 44: 94–104
   PubMed Web of Science ®Google Scholar
• Rydzewski RM, Bryant C, Oballa R, Wesolowski G, Rodan SB, Bass KE, Wong DH. Peptidic-1-cyanopyrrolidines: Synthesis and SAR of a series of potent, selective cathepsin inhibitors. Bioorg Med Chem 2002; 10: 3277–3284
   PubMedGoogle Scholar
• Greenspan PD, Clark KL, Tommasi RA, Cowen SD, McQuire LD, Farley DL, van Duzer JH, Goldberg RL, Zhou H, Fitt JJ, Coppa DE, Fang Z, Macchia W, Zhu L, Capparelli MP, Goldstein R, Wigg AM, Doughty JR, Bohacek RS, Knap AK. Identification of dipetidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design. J Med Chem 2001; 44: 4524–4534
   PubMed Web of Science ®Google Scholar
• Picken PP, Guthrie DJ, Walker B. Inhibition of bovine cathepsin B by amino acid-derived nitriles. Biochem Soc Trans 1990; 18: 316–416
   PubMedGoogle Scholar
• Ward YD, Thomson DS, Frye LL, Cywin CL, Morwick T, Emmanuel MJ, Zindell R, McNeil D, Bekkali Y, Girardot M, Hrapchak M, DeTuri M, Crane K, White D, Pav S, Wang Y, Hao M, Grygon CA, Labadia ME, Freeman DM, Davidson W, Hopkins JL, Brown ML, Spero DM. Design and synthesis of dipeptide nitriles as reversible and potent cathepsin S inhibitors. J Med Chem 2002; 45: 5471–5482
   PubMed Web of Science ®Google Scholar
• Bekkali Y, Thomson DS, Betageri R, Emmanuel MJ, Hao M, Hickey E, Liu W, Patel U, Ward YD, Young ERR, Nelson R, Kukulka A, Brown ML, Crane K, White D, Freeman DM, Labadia ME, Wildeson J, Spero DM. Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitors. Bioorg Med Chem Lett 2007; 17: 2465–2469
   PubMedGoogle Scholar
• Marquis RW, James I, Zeng J, Trout REL, Thompson S, Rahman A, Yamashita DS, Xie R, Ru Y, Gress CJ, Blake S, Lark MA, Hwang S, Tomaszek T, Offen P, Head MS, Cummings MD, Veber DF. Azepanone-based inhibitors of human cathepsin L. J Med Chem 2005; 48: 6870–6878
   PubMed Web of Science ®Google Scholar
• Organic Synthesis Collective Volume-VII., Freeman JP, Ed., John Willey and Sons Inc., New York, p 70-5.
   Google Scholar
• Vogel's Textbook of Practical Organic Chemistry. BS Furniss, AJ Hannaford, V Rogers, PGW Smith, AR Tatchell. ELBS publication. 1984; 801–803
   Google Scholar
• Nägler DK, Storer AC, Portaro FCV, Carmona E, Juliano L, Ménard R. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry 1997; 36: 12608–12615
   PubMed Web of Science ®Google Scholar
• Carmona E, Dufour E, Plouffe C, Takebe S, Manson P, Mort JS, Menard R. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry 1996; 35: 8149–8157
   PubMed Web of Science ®Google Scholar
• Olah GA, Narang SC, Fung AP, Gupta BG. Synthetic methods and reactions; part 82: Cyanuric chloride, a mild dehydrating agent in the preparation of nitriles from amides. Synthesis 1980; 657–658
   Google Scholar